Main Article Content

Sohaib Ahmad
Nadia Shirazi
Nowneet Kumar Bhat
Minakshi Dhar
Garima Mittal
Manish Mittal
Nidhi Kaeley
Manoj Kumar


severe malaria, cerebral malaria, outcome of malaria


Background & Objectives: Classically associated with Plasmodium falciparum, neurological complications in severe malaria is associated with increased morbidity and mortality. However, reports implicate the long considered benign Plasmodium vivax for causing severe malaria as well. We aimed to analyze the cerebral complications in malaria, and study if there is a specie-related difference in the presentation and outcomes.

Methods: We retrospectively compared patients of malaria hospitalised from 2009-15, with (n=105) and without (n=1155) neurological involvement in terms of outcomes, complications, demographic attributes, clinical features, and laboratory parameters. Subsequently, the same parameters were studied in those with cerebral malaria due to mono-infections of vivax or falciparum and their co-infection.

Results: Cerebral malaria was observed in 8.3% (58/696), 7.4% (38/513) and 17.6% (6/51) of vivax, falciparum and combined plasmodial infections respectively. Those with cerebral malaria had significantly (p<0.05) longer hospitalization, delayed defervescence, required mechanical ventilatory support and dialysis despite comparable levels of azotemia and renal insufficiency, and adverse outcomes compared to non-cerebral malaria. Severe thrombocytopenia, respiratory distress and mechanical ventilation were significantly (p<0.05) associated with P. vivax cerebral malaria.

Conclusions:The plasmodial species were comparable in clinical and laboratory parameters and outcomes in cerebral malaria in isolation and in combination (p>0.05). P. vivax emerged as the predominant cause of cerebral malaria and its virulence was comparable to P. falciparum.


Download data is not yet available.
Abstract 2915 | PDF Downloads 538 HTML Downloads 1328


1. Idro R, Jenkins NE, Newton CRJC. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005; 4: 827–40.

2. Martins YC, Carvalho LJM, Daniel-Ribeiro CT. Challenges in the Determination of Early Predictors of Cerebral Malaria: Lessons from the Human Disease and the Experimental Murine Models. Neuroimmunomodulation 2009;16:134–145

3. Idro R, Karamagi C, Tumwine J. Immediate outcome and prognostic factors for cerebral malaria among children admitted to Mulago Hospital, Uganda. Annals Trop Paedia 2004; 24: 17–24.

4. Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther 1998; 79:1–53

5. Brewster DR, Kwiatkowski D, White NJ. Neurological sequelae of cerebral malaria in children. Lancet 1990; 336:1039–43

6. van Hensbroek MB, Palmer A, Jaffar S, Schneider G, Kwiatkowski D. Residual neurologic sequelae after childhood cerebral malaria. J Pediatr 1997; 131:125–129

7. http://nvbdcp.gov.in/malaria3.html [accessed on 22.04.2016]

8. Oluwayemi OI, Brown BJ, Oyedeji OA, Adegoke SA, Adebami OJ, Oyedeji GA. Clinical and laboratory predictors of outcome in cerebral malaria in suburban Nigeria. J Infect Dev Ctries 2007; 7 (8): 600-7.

9. Sattar MA, Hoque HW, Amin MR, Faiz MA, Rahman MR. Neurological findings and outcome in adult cerebral malaria. Bangladesh Med Res Counc Bull 2009; 35: 15-17

10. Newton CRJC, Hien TT, White N. Cerebral malaria. J Neurol Neurosurg Psychiatry 2000 69: 433-441.

11. Angyo IA, Pam SO, Szlachetka R. Clinical pattern and outcome in patients with acute severe falciparum malaria at Jos University Teaching Hospital, Nigeria. East Afr Med J 1996; 73:823–6.

12. Saurabh Srivastava, Sohaib Ahmad, Nadia Shirazi, SK Verma, Prashant Puri. Retrospective analysis of vivax malaria patients presenting to tertiary referral centre of Uttarakhand. Acta Tropica 2011; 117: 82-85

13. Muntendam AH, Jaffar S, Bleichrodt N, van Hensbroek MB. Absence of neuropsychological sequelae following cerebral malaria in Gambian children. Trans R Soc Trop Med Hyg 1996; 90: 391-4

14. Ngoungou EB, Preux PM. Cerebral malaria and epilepsy. Epilepsia 2008; 49:19–24

15. Carter JA, Mung’ala-Odera V, Neville BG, Murira G, Mturi N, Musumba C, Newton CR. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry 2005; 76:476–81

16. John CC, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, Wu B, Boivin MJ. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics 2008; 122:e92–e99

17. Idro R, Marsh K, John CC, Newton CRJ. Cerebral Malaria: Mechanisms of Brain Injury and Strategies for Improved Neurocognitive Outcome. Paediat Res 2000; 68 (4): 267-74.

18. White NJ, Warrell DA, Chanthavanich P, et al. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med 1983;309:61–6.

19. Taylor TE, Molyneux ME, Wirima JJ, et al. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N Engl J Med 1988;319:1040–7.

20. Tripathy R, Parida S, Das L, Mishra DP, Tripathy D, Das MC, Chen H, Maguire JH, Panigrahi P. Clinical Manifestations and Predictors of Severe Malaria in Indian Children. Pediatrics 2007; 120 (3): e454-e460.

21. Mohapatra MK, Dash LK, Bariha PK, Karua PC: Profile of mixed species (Plasmodium vivax and falciparum) malaria in adults. J Assoc Physicians India. 2012, 60: 20-24.